Interruption of long-term warfarin is not necessary in patients undergoing total hip arthroplasty.

ABSTRACT:

Introduction

The management of anticoagulation in patients undergoing arthroplasty remains a challenge. Guidelines for perioperative management of long-term warfarin recommend discontinuation of warfarin preoperatively in low risk patients. We hypothesised that patients who had their warfarin continued during the perioperative period would have shorter hospital stay and no significant increase risk of surgical complications compared to patients who had their warfarin interrupted.

Methods

This was a retrospective review of 20 consecutive patients receiving long-term warfarin who underwent total hip replacement without stopping warfarin. As a control group, we collected same data from 20 age and gender matched patients also on long term warfarin but their warfarin was stopped

SUBMITTER: Mussa M 

PROVIDER: S-EPMC6919369 | biostudies-literature | 2020 Jan-Feb

REPOSITORIES: biostudies-literature